Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer

BACKGROUND: There are many molecular differences between estrogen receptor α (ERα)-positive and ER-negative breast cancers. Recent analyses have shown that the former can be divided into two subtypes, luminal A and luminal B. These differ in response to endocrine therapy and chemotherapy, and in pro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Endo, Yumi, Yamashita, Hiroko, Takahashi, Satoru, Sato, Shinya, Yoshimoto, Nobuyasu, Asano, Tomoko, Hato, Yukari, Dong, Yu, Fujii, Yoshitaka, Toyama, Tatsuya
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364092/
https://ncbi.nlm.nih.gov/pubmed/25528056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-990
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak